Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and vinorelbine, use different
ways to stop cancer cells from dividing so they stop growing or die. Combining more than one
drug may kill more cancer cells.
PURPOSE: This phase II trial is studying how well giving gemcitabine together with
vinorelbine works in treating young patients with recurrent or refractory Hodgkin's lymphoma.